Table 3.

Reggio Emilia Cancer Registry, years 2017–2018. 1-year and 3-year relative survival in the entire cohort and after categorizing by stage and MDT approach.

	1-Year						3-Year
	MDT Yes		MDT No		Total		MDT Yes		MDT No		Total
	%	95% CI	%	95% CI	%	95% CI	%	95% CI	%	95% CI	%	95% CI
Entire cohort	90.0	85.7–93.0	62.0	55.3–68.0	78.7	74.9–82.0	78.5	72.5–83.4	45.5	38.1–52.5	65.2	60.4–69.6
Stage
I	97.2	86.9–99.4	89.9	70.0–96.9	95.4	88.1–98.2	92.6	79.5–97.5	83.6	57.0–94.4	90.4	79.9–95.6
II	96.8	84.5–99.4	89.4	76.6–95.4	93.8	86.9–97.1	93.6	75.6–98.5	74.0	57.7–84.7	85.6	75.7–91.7
III	86.4	76.8–92.2	56.9	43.0–68.7	75.5	67.4–81.9	69.9	57.8–79.2	35.1	21.4–49.0	57.1	47.5–65.5
IV	63.7	47.3–76.1	27.4	18.6–36.8	42.1	33.3–50.7	29.2	16.0–43.7	5.1	1.4–11.5	14.7	8.7–22.1
T
T1–T2	97.8	87.9–99.6	92.2	71.9–98.0	96.5	89.7–98.9	92.8	81.7–97.3	89.4	60.2–97.6	92.1	82.7–96.5
T3–T4	87.9	81.9–92.1	71.5	62.2–78.9	81.6	76.6–85.7	74.8	66.5–81.3	49.8	39.4–59.3	65.2	58.8–70.9
N
N0	96.7	90.6–98.9	95.0	83.4–98.5	96.2	91.5–98.3	95.9	84.7–98.9	82.5	68.2–90.8	91.8	84.8–95.7
N1, N2, N+	85.4	76.4–91.2	63.2	47.6–75.3	78.5	70.7–84.5	61.5	50.2–70.9	32.1	19.2–45.8	52.4	43.4–60.5